SCHEMBL26423009

SCHEMBL26423009

Cc1cc2nc(C(F)(F)F)ccc2[nH]1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.41
MAPT P10636 6/20 0.40
KDM4E B2RXH2 4/20 0.40
POLB P06746 3/20 0.40
HPGD P15428 3/20 0.40
KEAP1 Q14145 2/20 0.38
CYP2A6 P11509 1/20 0.38
MEN1 O00255 4/20 0.37
KMT2A Q03164 4/20 0.37
NPSR1 Q6W5P4 2/20 0.37
NPC1 O15118 1/20 0.37
THRB P10828 1/20 0.37
PKM P14618 1/20 0.37
RAB9A P51151 1/20 0.37
AXL P30530 2/20 0.36
HSD17B10 Q99714 3/20 0.35
GAA P10253 1/20 0.35
NPBWR1 P48145 1/20 0.35
HSP90AA1 P07900 1/20 0.34
HSP90AB1 P08238 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26265751 0.83 MAPT (0.36) BRD4MAPTKDM4EPOLBHPGD
SCHEMBL19211915 0.81 KEAP1 (0.37) BRD4MAPTKDM4EHPGDKEAP1
SCHEMBL29594892 0.76 KEAP1 (0.41) MAPTKDM4EPOLBHPGDKEAP1
SCHEMBL19212554 0.76 KEAP1 (0.41) MAPTKDM4EPOLBHPGDKEAP1
SCHEMBL4904552 0.75 KEAP1 (0.44) MAPTKDM4EPOLBHPGDKEAP1
SCHEMBL30189253 0.73 KDM4E (0.47) MAPTKDM4EHPGDMEN1KMT2A
SCHEMBL831575 0.73 KDM4E (0.47) MAPTKDM4EHPGDMEN1KMT2A
SCHEMBL29543265 0.73 BRD4 (0.42) BRD4MAPTKDM4EHPGDMEN1
SCHEMBL831147 0.73 KDM4E (0.54) MAPTKDM4EHPGDMEN1KMT2A
SCHEMBL30147627 0.72 ALOX15 (0.46) BRD4MAPTKDM4EKMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230312481-A1 SUBSTITUTED (PHTHALAZIN-1-YLMETHYL)UREAS, SUBSTITUTED N-(PHTHALAZIN-1-YLMETHYL)AMIDES, AND ANALOGUES THEREOF ARBUTUS BIOPHARMA CORP (CA) 2023-10-05 US disclosed
US-20230312481-A1 SUBSTITUTED (PHTHALAZIN-1-YLMETHYL)UREAS, SUBSTITUTED N-(PHTHALAZIN-1-YLMETHYL)AMIDES, AND ANALOGUES THEREOF ARBUTUS BIOPHARMA CORP (CA) 2023-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230312481-A1 SUBSTITUTED (PHTHALAZIN-1-YLMETHYL)UREAS, SUBSTITUTED N-(PHTHALAZIN-1-YLMETHYL)AMIDES, AND ANALOGUES THEREOF NSD3, PML, NSD1 BRD4 180/4885MAPT 484/4885KDM4E 133/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.